Evkeeza 1200 MG per 8 ML Injection
- RxCUI
- 2478732
- RxNorm name
- Evkeeza 1200 MG per 8 ML Injection
- Display name
- Evkeeza 1200 MG per 8 ML Injection
- Full name
- Evkeeza 1200 MG per 8 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761181 | Evkeeza | evinacumab-dgnb | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 73412138-6d8f-4ea6-bb72-a740190470ff | Evkeeza 1200 MG in 8 ML Injection [PSN] · 8 ML evinacumab-dgnb 150 MG/ML Injection [Evkeeza] [SBD] · 8 ML Evkeeza 150 MG/ML Injection [SY] · Evkeeza 1200 MG per 8 ML Injection [SY] | 4 | 5 | These highlights do not include all the information needed to use EVKEEZA safely and effectively. See full prescribing information for EVKEEZA. EVKEEZA ® (evinacumab-dgnb) injection, for intravenous use Initial U.S. Approval: 2021 | 20250925 |